Additionally, the delivery of antisense oligonucleotides (ASOs) targeting ATXN2 to neuronal differentiated induced pluripotent stem cells (iPSCs) derived from C9orf72-ALS patients reversed the cytoplasmic mislocalization of nuclear proteins [57]. The gene discussed is ATXN2; the disease is amyotrophic lateral sclerosis.